Picture of Neuronetics logo

STIM Neuronetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Neuronetics Inc expected to post a loss of 8 cents a share - Earnings Preview

Neuronetics Inc STIM.OQ STIM.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2025

The Malvern Pennsylvania-based  company is expected to report a 123.7% increase in revenue to $36.8 million from $16.45 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on May 6 2025, for the period ended June 30, was for revenue between $36.00 million and $38.00 million.

​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 8 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Neuronetics Inc is $7.00, about 37.3% above its last closing price of $4.39

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.13-0.12-0.21Missed-68
Dec. 31 2025-0.25-0.21-0.33Missed-57.1
Sep. 30 2024-0.23-0.23-0.44Missed-91.3​
Jun. 30 2024-0.27-0.27-0.33Missed-22.2
​​Mar. 31 2024-0.32-0.31-0.27Beat12.9
Dec. 31 2023-0.26-0.26-0.19Beat27.3​
Sep. 30 2023-0.31-0.31-0.33Missed-6.7
Jun. 30 2023-0.35-0.35-0.17Beat51.2
This summary was machine generated August 1 at 13:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Neuronetics

See all news